Evidence map›Paper›PMID 29988994›Full record

ArticleKidney international reports2018

Twice-Weekly Hemodialysis and Clinical Outcomes in the China Dialysis Outcomes and Practice Patterns Study.

Yucheng Yan, Mia Wang, Jarcy Zee, Doug Schaubel, Charlotte Tu, JiaQi Qian, Brian Bieber, Mei Wang, Nan Chen, Zuo Li and 3 more

Abstract read
In one paragraph

Article in Kidney international reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Impact of incremental initiation of haemodialysis on mortality: a systematic review and meta-analysis.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2023
    Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Incremental Hemodialysis: What We Know so Far.International journal of nephrology and renovascular disease · 2022
    Review
  8. Review
  9. Observational
  10. Observational
  11. Incremental and Twice-Weekly Hemodialysis Program in Practice.Clinical journal of the American Society of Nephrology : CJASN · 2020
    Article
  12. Article
  13. Twice-Weekly Hemodialysis Is an Option for Many Patients in Times of Dialysis Unit Stress.Journal of the American Society of Nephrology : JASN · 2020
    Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yucheng YanDepartment of Nephrology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
Mia WangDepartment of Biostatistics, University of Michigan, Ann Arbor, Michigan, USA.
Jarcy ZeeArbor Research Collaborative for Health, Ann Arbor, Michigan, USA.
Doug SchaubelDepartment of Biostatistics, University of Michigan, Ann Arbor, Michigan, USA.
Charlotte TuArbor Research Collaborative for Health, Ann Arbor, Michigan, USA.
JiaQi QianRenal Division, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Brian BieberArbor Research Collaborative for Health, Ann Arbor, Michigan, USA.
Mei WangDepartment of Nephrology, People's Hospital, School of Medicine, Peking University, Beijing, China.
Nan ChenDepartment of Nephrology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Zuo LiPeking University First Hospital, Beijing, China Institute of Nephrology, Peking University, Beijing, China.
Friedrich K PortArbor Research Collaborative for Health, Ann Arbor, Michigan, USA.
Bruce M RobinsonArbor Research Collaborative for Health, Ann Arbor, Michigan, USA.
Shuchi AnandDivision of Nephrology, Stanford University School of Medicine, Palo Alto, California, USA.

Funding

TRAINING PROGRAM IN ACADEMIC NEPHROLOGYT32DK007357 · NIDDK · STANFORD UNIVERSITY · PI CHERTOW, GLENN MATTHEW · 1986 to 2022
$4.8M
Epidemiology and management of chronic kidney disease in South AsiansK23DK101826 · NIDDK · STANFORD UNIVERSITY · PI ANAND, SHUCHI · 2014 to 2018
$919k
NIDDK NIH HHS K23 DK101826NIDDK NIH HHS T32 DK007357
6 · The paper itself

Abstract

introductionIn China, a quarter of patients are undergoing 2-times weekly hemodialysis. Using data from the China Dialysis Outcomes and Practice Patterns Study (DOPPS), we tested the hypothesis that whereas survival and hospitalizations would be similar in the presence of residual kidney function (RKF), patients

methodsIn our cohort derived from 15 units randomly selected from each of 3 major cities (total N = 45), we generated a propensity score for the probability of dialysis frequency assignment, estimated a survival function by propensity score quintiles, and averaged stratum-specific survival functions to generate mean survival time. We used the proportional rates model to assess hospitalizations. We stratified all analyses by RKF, as reported by patients (urine output <1 vs. ≥1 cup/day).

resultsAmong 1265 patients, 123 and 133 were undergoing 2-times weekly hemodialysis with and without evidence of RKF. Over 2.5 years, adjusted mean survival times were similar for 2- versus 3-times weekly dialysis groups: 2.20 versus 2.23 and 2.20 versus 2.15 for patients with and without RKF (

conclusionIn our study of patients in China's major cities, we could not detect differences in survival and hospitalization for those undergoing 2- versus 3-times weekly dialysis, regardless of RKF. Our findings indicate the need for pragmatic studies regarding less frequent dialysis with associated nutritional management.

Indexed as

2-times weekly hemodialysisdialysis frequencydialysis provision in low-resource settingsoutcomes on hemodialysis

Identifiers

PMID29988994
PMCPMC6035134

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.